Sarilumab - Regeneron/Sanofi
At a glance
- Drug Originator Regeneron Pharmaceuticals; sanofi-aventis
- Drug Licenced by Asahi Kasei Pharma Corp
- Drug Class Anti-inflammatories; Antirheumatics; Antivirals; Monoclonal antibodies
- Mechanism of Action Interleukin 6 receptor antagonists
- USA Patent Applicants SANOFI SYNTHELABO
- USA Patents 33
- BLAs 1
- International Patents 69

Disclaimer